Several studies revealed that patients had abnormal liver function tests, including a moderate increase in bilirubin, aspartate aminotransferase (AST), and alanine aminotransferase (ALT), which are frequently observed in patients with severe COVID-19 compared with non-severe patients (167–169). The gene discussed is GPT; the disease is COVID-19.